Immune System News and Research

RSS

$52 million study to investigate why some infants develop lasting lung infections

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.

20 Oct 2026

Scientists discover immune pathway behind radiation-induced lung damage

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered an immune pathway that may contribute to radiation-related lung damage and have identified a potential strategy to block it.

20 Oct 2026

Study identifies initial cellular events in autoimmune kidney inflammation

When immunity works well, the body steers clear of infection and disease. However, when the immune system goes awry, healthy cells can often end up in the firing line.

19 Oct 2026

First patient dosed in Phase 1 clinical trial of new cancer drug

On August 18, 2026, in Japan, the Department of New Experimental Therapeutics and Early-Phase 1 Drug Development Service at Kansai Medical University Hospital, led by Professor Toshio SHIMIZU, administered DS1025 to the first patient worldwide as part of a global, multicenter First-in-Human Phase 1 clinical trial sponsored by Daiichi Sankyo.

19 Oct 2026

Study reveals mature immune functions in embryonic neutrophils

Neutrophils are white blood cells that form part of the body's first line of defence. Researchers have now demonstrated for the first time that neutrophils are found in many tissues during embryonic development, and that they can perform the same functions as adult neutrophils.

19 Oct 2026

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

16 Oct 2026

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data with its autologous PBMC (peripheral blood mononuclear cell) therapy APN401 in the peer-reviewed journal, Molecular Therapy Oncology.

16 Oct 2026

Parents know fruit and vegetables are healthy, but many underestimate how much children need

A qualitative study involving 15 Swedish parents found that although most recognized the health benefits of fruit and vegetables, many underestimated recommended daily intake and considered serving vegetables at dinner sufficient. Researchers identified four overlapping parental roles influencing children's eating habits and suggested that clearer guidance on quantities, serving frequency, and practical feeding approaches could help families improve consumption.

15 Oct 2026

Targeting the STING pathway could help prevent osteoporosis

As we age, our bones become weak and brittle, a process called osteoporosis. This bone loss is caused by changes in the cells within the bone marrow microenvironment, such as elevated fat and inflammation-promoting immune cells.

15 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

WEHI study reveals a new immune pathway for fighting small cell lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

14 Oct 2026

New immune profiling tool identifies antibodies that trigger preterm births

A typical pregnancy lasts 40 weeks, but for about 1 in 10 pregnant women labor begins too soon. Premature or preterm birth is the leading cause of newborn deaths worldwide.

14 Oct 2026

CSHL researchers find way to make immunotherapy effective against colorectal cancer

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

14 Oct 2026

Investigational knee injection targets cartilage loss in osteoarthritis patients

Keck Medicine of USC has launched a clinical trial testing the safety and tolerability of a new investigational treatment and its potential effects on preventing cartilage deterioration in people with knee osteoarthritis, the most common form of the disease.

14 Oct 2026

Researchers uncover how metastatic colorectal cancer evades immune attack

Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC).

13 Oct 2026

$5.8 million study explores gut-brain inflammation in people with HIV

Oregon Health & Science University researchers have secured a $5.8 million, five-year federal award to investigate whether damage to the gastrointestinal tract contributes to neuroinflammation in people living with HIV - raising the potential for new treatments to preserve brain function in people with HIV and older adults.

13 Oct 2026

Pregnancy reshapes the maternal brain through remarkable neurological changes

For generations, women have been told that the forgetfulness, emotional shifts, sensory changes, and altered sense of self that accompany pregnancy and new motherhood are simply "mommy brain."

13 Oct 2026

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

Results from a phase I clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers.

13 Oct 2026

Maternal opioid use in pregnancy linked to childhood hospitalizations

Children whose mothers received opioid prescriptions during pregnancy have a higher rate of hospital admission in childhood than unexposed children, including unexposed siblings, according to a new study published October 13th in the open access journal PLOS Medicine by Dong Keon Yon of Kyung Hee University College of Medicine, South Korea, and colleagues.

13 Oct 2026

Scientists find strange bacterial immune system that works backward

Researchers at Gladstone Institutes have uncovered an extraordinarily unusual bacterial immune system that operates in reverse of known defenses.

13 Oct 2026

Immune System News and Research

$52 million study to investigate why some infants develop lasting lung infections

Scientists discover immune pathway behind radiation-induced lung damage

Study identifies initial cellular events in autoimmune kidney inflammation

First patient dosed in Phase 1 clinical trial of new cancer drug

Study reveals mature immune functions in embryonic neutrophils

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

Parents know fruit and vegetables are healthy, but many underestimate how much children need

Targeting the STING pathway could help prevent osteoporosis

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

WEHI study reveals a new immune pathway for fighting small cell lung cancer

New immune profiling tool identifies antibodies that trigger preterm births

CSHL researchers find way to make immunotherapy effective against colorectal cancer

Investigational knee injection targets cartilage loss in osteoarthritis patients

Researchers uncover how metastatic colorectal cancer evades immune attack

$5.8 million study explores gut-brain inflammation in people with HIV

Pregnancy reshapes the maternal brain through remarkable neurological changes

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

Maternal opioid use in pregnancy linked to childhood hospitalizations

Scientists find strange bacterial immune system that works backward

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News